Omidenepag isopropyl | Interleukin Related interleukin-related.com

Product Name :
Omidenepag isopropyl

Search keywords :
Omidenepag isopropyl

drugId :
null

Target Vo:
Prostanoid EP2 receptor

Target Vo Short Name :
PTGER2

Moa_Name:
Prostanoid EP2 receptor agonists

First Approval Country :
Japan

First Approval Date Filter:
2018

Origin Company_Name :
Ube Industries Ltd

Active Company_Name :
Santen

Active Indication_Name:
Ocular Hypertension

In Active Indication_Name:
Glaucoma, Open-Angle

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
4E BP1 Antibody
Phospho-Hsp27 (Ser82) Antibody
CHRNA9 Antibody: CHRNA9 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CHRNA9 polyclonal antibody. CHRNA9 Antibody can be used for: WB, IHC-P expriments in human, rat background without labeling.

Author: Interleukin Related

Related Posts